Nalaganje...
Dasatinib suppresses invasion and induces apoptosis in nasopharyngeal carcinoma
Dasatinib, an orally available tyrosine kinas inhibitor (TKI), potently inhibits SRC which was found to activate RTKs that induce trastuzumab de novo and acquired resistance. To evaluate the potential of Dasatinib in the treatment of Nasopharyngeal Carcinoma, we used a variety of assays to measure i...
Shranjeno v:
| izdano v: | Int J Clin Exp Pathol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
e-Century Publishing Corporation
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4555674/ https://ncbi.nlm.nih.gov/pubmed/26339346 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|